Clinical outcomes and health care costs combining metformin with sitagliptin or sulphonylureas or thiazolidinediones in uncontrolled type 2 diabetes patients

OBJECTIVES: To compare clinical outcomes and health care costs across three cohorts of uncontrolled diabetic patients who initiated treatment with one of the following: sulphonylureas (SU), thiazolidinediones (TZD) or sitagliptin (SITA). MATERIALS AND METHODS: We performed a retrospective study base...

Full description

Saved in:
Bibliographic Details
Main Authors: Degli Esposti, Luca, Saragoni, Stefania, Buda, Stefano, Degli Esposti, Ezio
Format: Artigo
Language:Inglês
Published: Dove Medical Press 2014
Subjects:
Original Research
Online Access:https://ncbi.nlm.nih.gov/pmc/articles/PMC4211865/
https://ncbi.nlm.nih.gov/pubmed/25364266
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.2147/CEOR.S63666
Tags: Add Tag
No Tags, Be the first to tag this record!

Similar Items